{"disease":{"id":"hyperglycemia-drug-induced","name":"hyperglycemia drug induced"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06685991","title":"Effect of Timing of Dexamethasone During Induction on Postoperative Outcomes","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"AABDI Mohammed","has_results":false},{"nct_id":"NCT03076775","title":"Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":true},{"nct_id":"NCT05753657","title":"A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Rambam Health Care Campus","has_results":false},{"nct_id":"NCT04330625","title":"Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT04253223","title":"A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisib","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Duke University","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}